We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Stomach Stapling Linked to Nerve Injury

By HospiMedica staff writers
Posted on 27 Oct 2004
A study has found that a significant number of patients who undergo gastric bypass surgery, or stomach stapling, for weight reduction develop peripheral neuropathy, which is damage to the nerves outside the brain and spinal cord.

Since the development of nerve damage is associated with malnutrition, investigators from the Mayo Clinic (Rochester, MN, USA) contend that the damage may be largely preventable with proper nutritional care. More...
They found that 16% of the weight-reduction surgery patients they studied developed peripheral neuropathy, ranging from minor tingling or numbness to severe pain and weakness confining patients to wheelchairs.

"Surgeons who do weight-reduction surgery and the general public should be aware that nerve damage is a frequent consequence of the surgery,” noted lead investigator P. James Dyck, M.D., a Mayo Clinic neurologist. "But patients who were part of nutritional programs before and after their weight-loss surgery generally didn't develop these neuropathies, so we believe the nerve damage is large preventable.”

The researchers identified four risk factors in patients who developed nerve problems: they lost weight much faster, they received less nutritional supplementation, they experienced prolonged nausea and vomiting, and they failed to attend nutritional clinics.
"The evidence is very strong that nerve complications are associated with malnutrition and neuropathy,” concluded Dr. Dyck. The findings were reported in the October 26, 2004, issue of Neurology.




Related Links:
Mayo Clinic

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.